Tuesday, May 24, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | India | Serum Institute Applies For Trials Of Another Covid 19 Vaccine

Serum Institute applies for trials of another COVID-19 vaccine

By PTI
Published: Published Date - 06:05 PM, Sat - 30 January 21
The city-based firm has already produced Covishield vaccine, co-developed by the University of Oxford and British-Swedish company AstraZeneca.

Pune: Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said his company has applied to start the trials of another COVID-19 vaccine and that it hopes to launch it by June 2021.

The city-based firm has already produced Covishield vaccine, co-developed by the University of Oxford and British-Swedish company AstraZeneca. The Centre has purchased 11 million doses of Covishield vaccine for the ongoing inoculation drive.

In a tweet, Poonawalla said, “Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!” The country launched its COVID-19 vaccination drive from January 16 in what Prime Minister Narendra Modi has called the world’s largest inoculation programme with priority to be given to nearly three crore healthcare and frontline workers.

Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!

— Adar Poonawalla (@adarpoonawalla) January 30, 2021

  • Follow Us :
  • Tags
  • Adar Poonawalla
  • AstraZeneca
  • COVID-19 vaccine
  • Covishield vaccine

Related News

  • Traffic restrictions in Hyderabad on Thursday

  • Quad to cooperate on disaster risk reduction through CDRI

  • Pfizer says Covid shot 80% effective in young kids

  • Free, inclusive Indo-Pacific region a shared goal of Quad: Modi in Tokyo

  • V-P, PM express gratitude to Indian scientists on National Technology Day

  • Poonawalla woos Musk to invest in making Tesla cars in India

Latest News

  • Opinion: The new cold war will be fiercer

    4 hours ago
  • Editorial: Opening doors for regional cooperation

    4 hours ago
  • Cyber fraudsters swindle Rs 2.7 crore using ‘investment bait’ in Cyberabad

    4 hours ago
  • IPL 2022: Gujarat Titans qualify for final with seven-wicket win over RR

    4 hours ago
  • Nutreat offers healthy, nutritious food using traditional techniques

    4 hours ago
  • Q&A session on steps to achieve success amid competition in TT, NT’s awareness programme

    5 hours ago
  • Telangana’s Lavanya makes it to Indian team for U-20 Asian Volleyball Championship

    5 hours ago
  • Think positive, improve skills experts tell aspirants in TT, NT’s awareness programme

    5 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam